Elon Musk's Brain chip company sued by pregnant woman for Herpes Monkeys. - podcast episode cover

Elon Musk's Brain chip company sued by pregnant woman for Herpes Monkeys.

Jun 19, 20246 min
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

Neuralink, the brain-implant startup founded by Elon Musk, is facing legal action from a former employee, Lindsay Short, who claims she was forced to work with monkeys carrying the Herpes B virus under unsafe conditions. The complaint, filed in California state court, also alleges retaliation and wrongful termination following her announcement of pregnancy.

Transcript

Hey everybody, welcome back to the Elon Musk Podcast. This is a show where we discuss the critical crossroads, the Shape, SpaceX, Tesla X, The Boring Company and Neuralink. I'm your host Will Walden. Neuralink, the brain implant startup founded by Elon Musk, is facing legal action from a former employee, Lindsay Short, who claimed she was forced to work with monkeys carrying the herpes B virus under unsafe

conditions. The complaint, filed in California State court, also alleges retaliation and wrongful termination following her announcement of pregnancy. Short, who joined Neuralinks Fremont, CA site in August of 2022, describes a toxic work environment marked by blame, shame, and unrealistic deadlines. She alleges that the company failed to provide proper protective gear while she worked with herpes bee infected monkeys, leading to incidents where she was scratched through

a glove and on her face. Now, the lawsuit claims that after seeking medical treatment for the scratches, Short was threatened with severe repercussions if she insisted on medical attention in the future, and Neuralink did not immediately respond to a request for comment on these allegations. Short also contends that the company did not honor its promise of flexible work hours to accommodate her family, instead demoting her in May of 2023, just two months after her promotion.

She was fired the day after informing Neurolink's human resources department of her pregnancy with a company setting performance issues. The Neurolink has been in the early stages of clinical trials for his brain implant device, which aims to restore function for paralyzed patients.

Recently, a quadriplegic became the first human patient to receive the implant, enabling him to play video games using only his thoughts, and the company has faced criticism and scrutiny over its Treatment of Animals. Past research on monkeys at the University of California, Davis and included botched surgeries that resulted in severe complications and deaths, prompting Neuralink to move its

monkey research in house. A federal investigation by the US Department of Agriculture's Inspector General was launched into Neuralink over potential animal welfare violations. This probe followed internal complaints. The Musk's pressure to accelerate development led to rushed and flawed animal tests, causing unnecessary suffering

and also deaths. An animal rights group, Physicians Committee for Responsible Medicine, accused Neuralink and UC Davis of using incorrect surgical methods, leading to significant suffering of the test animals. Musk has previously expressed his reluctance to use animals and research, but has emphasized the necessity for rapid progress in developing technologies to accept people with severe

disabilities. Now, in an effort to address public concerns, Neuralink has reportedly made efforts to improve living conditions for his test animals, creating facilities referred to as Monkey Disneyland or the Monkey Taj Mahal. And despite these efforts, backlash against the company's animal testing practices

persists. Neuralink's legal and ethical challenges reflect broader issues faced by companies in the high stakes field of medical research, where the urgency to deliver results can conflict with ethical and regulatory standards. The scrutiny over Neuralink's treatment of both employees and animals is expected to increase as the company continues its development efforts. Lindsay Short's lawsuit is not an isolated case of alleged gender discrimination within Musk's companies.

Similar allegations have been made against SpaceX, where former employees have claimed wrongful termination after raising concerns about sexual harassment. Reports indicate that as many as a dozen suffered from severe systems, including brain swelling, partial paralysis and self harming behavior after being implanted with neuralinks. Chimps. That's the monkeys. These incidents have fueled ongoing controversy surrounding

the company's research methods. Musk has denied claims of improper treatment of the test animals, asserting that the affected monkeys were terminally ill prior to receiving the implants. However, he has not provided substantial evidence to support these statements. Short's case also highlights alleged violations of transportation regulations by Neuralink.

U.S. Department of Transportation is investigating the illegal movement of implants removed from monkey brains, which may have been contaminated with Herpes B and other hard to kill bacteria. Now, these allegations, if proven true, paint a disturbing picture of Neuralink's operational practices. The company's handling of both its employees and test animals could lead to further legal and ethical repercussions.

Neuralink's approach to rapid development has involved repeated testing without fully addressing issues from earlier experiments. This has raised concerns among current and former employees about the quality of data and the ethical implications of the company's methods. And despite these controversies, Neuralink continues its mission to develop brain implant technology that can potentially transform the lives of individuals with severe

disabilities. The balance between scientific advancement and ethical responsibility remains a critical aspect of its operations, and the outcome of Schwartz's lawsuit may have broader implications for workplace practices and animal welfare standards. Within the field of biomedical research. And as Neuralink progresses with its clinical trials, the scrutiny over its treatment of employees and animals is

expected to remain intense. Neuralink's current legal issues, coupled with past controversies over animal treatment highlights significant challenges in balancing this rapid technology development with ethical consideration. The resolution of these issues will be crucial for the company's future. Hey, thank you so much for listening today. I really do appreciate your

support. If you could take a second and hit the subscribe or the follow button on whatever podcast platform that you're listening on right now, I greatly appreciate it. It helps out the show tremendously and you'll never miss an episode. And each episode is about 10 minutes or less to get you caught up quickly. And please, if you want to support the show even more, go to patreon.com/stage Zero and please take care of yourselves and each other and I'll see you tomorrow.

Transcript source: Provided by creator in RSS feed: download file
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast